These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
122 related articles for article (PubMed ID: 3376129)
1. Vagal tone monitoring: a potential indicator of anti-cholinesterase exposure in Macaca mulatta. Dellinger JA; Jansen HT; Zaber DJ; Birnbaum SG Toxicology; 1988 May; 49(2-3):227-35. PubMed ID: 3376129 [TBL] [Abstract][Full Text] [Related]
2. The use of carbamates, atropine, and 2-pyridine aldoxime methoiodide in the protection of Artemia salina against poisoning by carbophenothion. Sánchez-Fortún S; Barahona V Environ Toxicol Chem; 2001 Sep; 20(9):2008-13. PubMed ID: 11521828 [TBL] [Abstract][Full Text] [Related]
3. Quantifying the altered cardiac response to atropine following pyridostigmine in rhesus macaques. Birnbaum SG; Richardson BC; Dellinger JA Pharmacol Biochem Behav; 1988 Oct; 31(2):381-6. PubMed ID: 3244715 [TBL] [Abstract][Full Text] [Related]
4. Efficacy of antidotes and their combinations in the treatment of acute carbamate poisoning in rats. Stojiljković MP; Škrbić R; Jokanović M; Kilibarda V; Bokonjić D; Vulović M Toxicology; 2018 Sep; 408():113-124. PubMed ID: 30176331 [TBL] [Abstract][Full Text] [Related]
5. In vitro kinetic interactions of pyridostigmine, physostigmine and soman with erythrocyte and muscle acetylcholinesterase from different species. Herkert NM; Thiermann H; Worek F Toxicol Lett; 2011 Sep; 206(1):41-6. PubMed ID: 21414391 [TBL] [Abstract][Full Text] [Related]
6. Evaluation of the efficacy of two carbamates, physostigmine and pyridostigmine, when used in conjunction for protection against organophosphate exposure. Solana RP; Gennings C; Carter WH; Anderson D; Lennox WJ; Carchman RA; Harris LW Fundam Appl Toxicol; 1990 Nov; 15(4):814-9. PubMed ID: 2086320 [TBL] [Abstract][Full Text] [Related]
7. Pretreatment for acute exposure to diisopropylfluorophosphate: in vivo efficacy of various acetylcholinesterase inhibitors. Lorke DE; Hasan MY; Nurulain SM; Shafiullah M; Kuča K; Petroianu GA J Appl Toxicol; 2011 Aug; 31(6):515-23. PubMed ID: 20981864 [TBL] [Abstract][Full Text] [Related]
8. In vitro effects of various cholinesterase inhibitors on acetyl- and butyrylcholinesterase of healthy volunteers. Thomsen T; Zendeh B; Fischer JP; Kewitz H Biochem Pharmacol; 1991 Jan; 41(1):139-41. PubMed ID: 1986738 [No Abstract] [Full Text] [Related]
9. Effect of pyridostigmine pretreatment on cardiorespiratory function in tabun poisoning. Worek F; Kleine A; Szinicz L Hum Exp Toxicol; 1995 Aug; 14(8):634-42. PubMed ID: 7576830 [TBL] [Abstract][Full Text] [Related]
10. Effects of atropine on respiratory sinus arrhythmia (RSA) in the rhesus macaque. Jansen HT; Dellinger JA Neurotoxicol Teratol; 1988; 10(2):169-74. PubMed ID: 3398825 [TBL] [Abstract][Full Text] [Related]
11. Toxicity and characterization of cholinesterase-inhibition induced by diisopropyl fluorophosphate in Artemia salina larvae. Sánchez-Fortún S; Barahona MV Ecotoxicol Environ Saf; 2009 Mar; 72(3):775-80. PubMed ID: 18191451 [TBL] [Abstract][Full Text] [Related]
12. The combined effects of pyridostigmine and chronic stress on brain cortical and blood acetylcholinesterase, corticosterone, prolactin and alternation performance in rats. Kant GJ; Bauman RA; Feaster SR; Anderson SM; Saviolakis GA; Garcia GE Pharmacol Biochem Behav; 2001; 70(2-3):209-18. PubMed ID: 11701190 [TBL] [Abstract][Full Text] [Related]
13. Latent dichlorvos neurotoxicity detected by vagal tone monitoring in dogs. Dellinger JA; McKiernan BC; Koritz GD; Richardson BC Neurotoxicol Teratol; 1987; 9(3):197-201. PubMed ID: 3627083 [TBL] [Abstract][Full Text] [Related]
14. Stress does not enable pyridostigmine to inhibit brain cholinesterase after parenteral administration. Grauer E; Alkalai D; Kapon J; Cohen G; Raveh L Toxicol Appl Pharmacol; 2000 May; 164(3):301-4. PubMed ID: 10799340 [TBL] [Abstract][Full Text] [Related]
15. Cholinergic control of growth hormone (GH) responses to GH-releasing hormone in insulin dependent diabetics: evidence for attenuated hypothalamic somatostatinergic tone and decreased GH autofeedback. Ismail IS; Scanlon MF; Peters JR Clin Endocrinol (Oxf); 1993 Feb; 38(2):149-57. PubMed ID: 8094648 [TBL] [Abstract][Full Text] [Related]
16. Kinetic analysis of the protection afforded by reversible inhibitors against irreversible inhibition of acetylcholinesterase by highly toxic organophosphorus compounds. Eckert S; Eyer P; Mückter H; Worek F Biochem Pharmacol; 2006 Jul; 72(3):344-57. PubMed ID: 16780806 [TBL] [Abstract][Full Text] [Related]
17. Increase in parasympathetic tone by pyridostigmine prevents ventricular dysfunction during the onset of heart failure. Lataro RM; Silva CA; Fazan R; Rossi MA; Prado CM; Godinho RO; Salgado HC Am J Physiol Regul Integr Comp Physiol; 2013 Oct; 305(8):R908-16. PubMed ID: 23948774 [TBL] [Abstract][Full Text] [Related]
18. Effects of chronic cholinergic stimulation associated with aerobic physical training on cardiac morphofunctional and autonomic parameters in spontaneously hypertensive rats. Gardim CB; Veiga AC; Aguilar BA; Philbois SV; Souza HCD Sci Rep; 2021 Aug; 11(1):17141. PubMed ID: 34433865 [TBL] [Abstract][Full Text] [Related]
19. Cholinergic stimulation with pyridostigmine protects myocardial infarcted rats against ischemic-induced arrhythmias and preserves connexin43 protein. Santos-Almeida FM; Girão H; da Silva CA; Salgado HC; Fazan R Am J Physiol Heart Circ Physiol; 2015 Jan; 308(2):H101-7. PubMed ID: 25416192 [TBL] [Abstract][Full Text] [Related]
20. Subacute pyridostigmine exposure increases heart rate recovery and cardiac parasympathetic tone in rats. Bharadwaj M; Pope C; Davis M; Katz S; Cook C; Maxwell L Clin Exp Pharmacol Physiol; 2017 Aug; 44(8):872-879. PubMed ID: 28440910 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]